Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis : A spotlight on the contribution of the endosome-lysosome system
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved..
The highly heterogenous nature of colorectal cancer can significantly hinder its early and accurate diagnosis, eventually contributing to high mortality rates. The adenoma-carcinoma sequence and serrated polyp-carcinoma sequence are the two most common sequences in sporadic colorectal cancer. Genetic alterations in adenomatous polyposis coli (APC), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and tumour protein 53 (TP53) genes are critical in adenoma-carcinoma sequence, whereas v-Raf murine sarcoma viral oncogene homolog B (BRAF) and MutL Homolog1 (MLH1) are driving oncogenes in the serrated polyp-carcinoma sequence. Sporadic mutations in these genes contribute differently to colorectal cancer pathogenesis by introducing distinct alterations in several signalling pathways that rely on the endosome-lysosome system. Unsurprisingly, the endosome-lysosome system plays a pivotal role in the hallmarks of cancer and contributes to specialised colon function. Thus, the endosome-lysosome system might be distinctively influenced by different mutations and these alterations may contribute to the heterogenous nature of sporadic colorectal cancer. This review highlights potential connections between major sporadic colorectal cancer mutations and the diverse pathogenic mechanisms driven by the endosome-lysosome system in colorectal carcinogenesis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:585 |
|---|---|
| Enthalten in: |
Cancer letters - 585(2024) vom: 31. März, Seite 216639 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tang, Jingying [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
BRAF |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 05.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.canlet.2024.216639 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367809788 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367809788 | ||
| 003 | DE-627 | ||
| 005 | 20240305232254.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240131s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canlet.2024.216639 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM367809788 | ||
| 035 | |a (NLM)38290660 | ||
| 035 | |a (PII)S0304-3835(24)00033-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tang, Jingying |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis |b A spotlight on the contribution of the endosome-lysosome system |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 05.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a The highly heterogenous nature of colorectal cancer can significantly hinder its early and accurate diagnosis, eventually contributing to high mortality rates. The adenoma-carcinoma sequence and serrated polyp-carcinoma sequence are the two most common sequences in sporadic colorectal cancer. Genetic alterations in adenomatous polyposis coli (APC), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and tumour protein 53 (TP53) genes are critical in adenoma-carcinoma sequence, whereas v-Raf murine sarcoma viral oncogene homolog B (BRAF) and MutL Homolog1 (MLH1) are driving oncogenes in the serrated polyp-carcinoma sequence. Sporadic mutations in these genes contribute differently to colorectal cancer pathogenesis by introducing distinct alterations in several signalling pathways that rely on the endosome-lysosome system. Unsurprisingly, the endosome-lysosome system plays a pivotal role in the hallmarks of cancer and contributes to specialised colon function. Thus, the endosome-lysosome system might be distinctively influenced by different mutations and these alterations may contribute to the heterogenous nature of sporadic colorectal cancer. This review highlights potential connections between major sporadic colorectal cancer mutations and the diverse pathogenic mechanisms driven by the endosome-lysosome system in colorectal carcinogenesis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a BRAF | |
| 650 | 4 | |a CRC | |
| 650 | 4 | |a Endosome-lysosome | |
| 650 | 4 | |a KRAS | |
| 650 | 4 | |a Pathogenesis | |
| 650 | 7 | |a Proto-Oncogene Proteins B-raf |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins p21(ras) |2 NLM | |
| 650 | 7 | |a EC 3.6.5.2 |2 NLM | |
| 650 | 7 | |a KRAS protein, human |2 NLM | |
| 650 | 7 | |a BRAF protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 700 | 1 | |a Lam, Giang T |e verfasserin |4 aut | |
| 700 | 1 | |a Brooks, Robert D |e verfasserin |4 aut | |
| 700 | 1 | |a Miles, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Useckaite, Zivile |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Ian Rd |e verfasserin |4 aut | |
| 700 | 1 | |a Ung, Ben S-Y |e verfasserin |4 aut | |
| 700 | 1 | |a Martini, Carmela |e verfasserin |4 aut | |
| 700 | 1 | |a Karageorgos, Litsa |e verfasserin |4 aut | |
| 700 | 1 | |a Hickey, Shane M |e verfasserin |4 aut | |
| 700 | 1 | |a Selemidis, Stavros |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, Ashley M |e verfasserin |4 aut | |
| 700 | 1 | |a Rowland, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Vather, Ryash |e verfasserin |4 aut | |
| 700 | 1 | |a O'Leary, John J |e verfasserin |4 aut | |
| 700 | 1 | |a Brooks, Douglas A |e verfasserin |4 aut | |
| 700 | 1 | |a Caruso, Maria C |e verfasserin |4 aut | |
| 700 | 1 | |a Logan, Jessica M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer letters |d 1976 |g 585(2024) vom: 31. März, Seite 216639 |w (DE-627)NLM000147273 |x 1872-7980 |7 nnns |
| 773 | 1 | 8 | |g volume:585 |g year:2024 |g day:31 |g month:03 |g pages:216639 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canlet.2024.216639 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 585 |j 2024 |b 31 |c 03 |h 216639 | ||